Cargando…

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines

SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced immunity rapidly declines. Immune responses in respiratory tract mucosal tissues are crucial for early control of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraser, Rupsha, Orta-Resendiz, Aurelio, Mazein, Alexander, Dockrell, David H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2023
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868365/ https://www.ncbi.nlm.nih.gov/pubmed/36764906 http://dx.doi.org/10.1016/j.molmed.2023.01.003

Ejemplares similares

Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
por: Fraser, Rupsha, et al.
Publicado: (2023)

Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds
por: Lichtenstein, Moria, et al.
Publicado: (2021)

Mucosal immune responses to infection and vaccination in the respiratory tract
por: Mettelman, Robert C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
por: Mullbacher, Arno, et al.
Publicado: (2020)

Mucosal Vaccination via the Respiratory Tract
por: Hellfritzsch, Marie, et al.
Publicado: (2019)

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
por: Mitsi, Elena, et al.
Publicado: (2023)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2
por: Ramasamy, Ranjan
Publicado: (2022)

COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
por: Ramasamy, Ranjan
Publicado: (2023)

‘Nutrimune(®)’ and immune defence against pathogens in the gastrointestinal and upper respiratory tracts: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
por: Turck, Dominique, et al.
Publicado: (2017)

Nutrimune and immune defence against pathogens in the gastrointestinal and upper respiratory tracts: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
por: Turck, Dominique, et al.
Publicado: (2019)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

An Appropriate Lower Respiratory Tract Specimen Is Essential for Diagnosis of Middle East Respiratory Syndrome (MERS)
por: Lee, Jae Hoon, et al.
Publicado: (2015)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
por: Tang, Jinyi, et al.
Publicado: (2022)

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)

Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination
por: Mades, Aubree, et al.
Publicado: (2021)

The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2
por: Li, Wendy, et al.
Publicado: (2022)

Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
por: Baldari, Cosima T., et al.
Publicado: (2023)

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

Nonspecific Effects of Infant Vaccines Make Children More Resistant to SARS-CoV-2 Infection
por: Fonte, Luis, et al.
Publicado: (2022)

Upper Respiratory Symptoms, Gut Health and Mucosal Immunity in Athletes
por: Colbey, Candice, et al.
Publicado: (2018)

In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction
por: Silva-Arrieta, Sandra, et al.
Publicado: (2020)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection
por: Krüger, Nadine, et al.
Publicado: (2021)

Alpha and Omicron SARS-CoV-2 Adaptation in an Upper Respiratory Tract Model
por: Mathez, Gregory, et al.
Publicado: (2022)

Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
por: Breiman, Adrien, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for
por: Thompson, Marcos A., et al.
Publicado: (2023)

Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19?
por: Dockrell, David H., et al.
Publicado: (2022)

Structure, Organization, and Development of the Mucosal Immune System of the Respiratory Tract
por: Randall, Troy D.
Publicado: (2015)

DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
por: Oberemok, Volodymyr V., et al.
Publicado: (2023)

The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs
por: Shah, Masaud, et al.
Publicado: (2022)

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome
por: Rosas-Salazar, Christian, et al.
Publicado: (2021)

Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract
por: Farr, Ryan J., et al.
Publicado: (2022)

Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection
por: Li, Jiarui, et al.
Publicado: (2023)

Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +
por: Bellato, Massimo, et al.
Publicado: (2023)

No Evidence of SARS-CoV-2 Seminal Shedding Despite SARS-CoV-2 Persistence in the Upper Respiratory Tract
por: Rawlings, Stephen A, et al.
Publicado: (2020)

Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
por: De Angelis, Maria Laura, et al.
Publicado: (2021)

T Cells: Warriors of SARS-CoV-2 Infection
por: de Candia, Paola, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5vju3mrtg85p75m01bdejif0rn